These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19480274)

  • 1. The role of C-reactive protein (CRP) and statin treatment in reducing cardiovascular risk.
    Chin J
    S D Med; 2009 Mar; 62(3):104-6. PubMed ID: 19480274
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin therapy in primary prevention: new insights regarding women and the elderly.
    Harrington C; Horne A; Hasan RK; Blumenthal RS
    Am J Cardiol; 2010 Nov; 106(9):1357-9. PubMed ID: 21029838
    [No Abstract]   [Full Text] [Related]  

  • 3. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
    Stewart RA
    Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
    Couzin J
    Science; 2008 Nov; 322(5904):1039. PubMed ID: 19008423
    [No Abstract]   [Full Text] [Related]  

  • 5. [The JUPITER study].
    Gaspardone A; Maseri A
    G Ital Cardiol (Rome); 2009 May; 10(5):267-70. PubMed ID: 19537439
    [No Abstract]   [Full Text] [Related]  

  • 6. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein.
    Ridker PM; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Khurmi NS; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Am J Cardiol; 2007 Dec; 100(11):1659-64. PubMed ID: 18036365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: the JUPITER study.
    Cardiovasc J Afr; 2008; 19(6):332-4, discussion 335. PubMed ID: 19104734
    [No Abstract]   [Full Text] [Related]  

  • 8. Statin therapy for elevated hsCRP: more evidence is needed.
    Molokwu OC
    Am J Manag Care; 2010 Aug; 16(8):565-6. PubMed ID: 20712389
    [No Abstract]   [Full Text] [Related]  

  • 9. [JUPITER no support of changed guidelines for cardiovascular prevention. Moderate absolute risk reduction and uncertain long term effects].
    Håkansson J
    Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1460-1. PubMed ID: 19579433
    [No Abstract]   [Full Text] [Related]  

  • 10. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
    Olsson AG
    Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
    [No Abstract]   [Full Text] [Related]  

  • 11. Was the FDA misled by JUPITER?
    MacDonald GP
    J Am Osteopath Assoc; 2010 Aug; 110(8):424-5. PubMed ID: 20805547
    [No Abstract]   [Full Text] [Related]  

  • 12. [Less vascular risk with rosuvastatin in elevated CRP].
    Bredie B
    Ned Tijdschr Geneeskd; 2009 Feb; 153(6):245. PubMed ID: 19271446
    [No Abstract]   [Full Text] [Related]  

  • 13. Statin therapy for elevated hsCRP: what are the public health implications?
    Ridker PM
    Am J Manag Care; 2010 Aug; 16(8):561-2. PubMed ID: 20712388
    [No Abstract]   [Full Text] [Related]  

  • 14. [JUPITER study about rosuvastatin and risk of cardiovascular disease. Unclear consequences for the guideline].
    Lubsen J
    Ned Tijdschr Geneeskd; 2009 Feb; 153(6):216-7. PubMed ID: 19271438
    [No Abstract]   [Full Text] [Related]  

  • 15. The JUPITER trial: How will it change clinical practice?
    Watson KE
    Rev Cardiovasc Med; 2009; 10(2):91-6. PubMed ID: 19593321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [JUPITER study (2). For now no reason to give statins to more people].
    Koopmans RP
    Ned Tijdschr Geneeskd; 2009 Feb; 153(6):218-9. PubMed ID: 19271439
    [No Abstract]   [Full Text] [Related]  

  • 17. [Statin cuts cardiovascular risk in half].
    Einecke D
    MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
    [No Abstract]   [Full Text] [Related]  

  • 18. Statin, the black box.
    Hatem S; Boccara F
    Arch Cardiovasc Dis; 2008 Jun; 101(6):377-9. PubMed ID: 18809149
    [No Abstract]   [Full Text] [Related]  

  • 19. The numbers are in: statins for the primary prevention of cardiovascular disease in women.
    Duvernoy CS; Blumenthal R
    Circulation; 2010 Mar; 121(9):1063-5. PubMed ID: 20176993
    [No Abstract]   [Full Text] [Related]  

  • 20. JUPITER strikes earth.
    Fuster V; Bansilal S
    Nat Clin Pract Cardiovasc Med; 2009 Mar; 6(3):159. PubMed ID: 19234496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.